Work

Supplementary Methods, Tables 1 - 4, Figures 1 - 10 from Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1: Change in immune response by treatment group and HPV status for analyzed cohort n=32. Supplementary Table 2: Change in immune response by treatment group and HPV status for intent to treat cohort. Supplementary Table 3: Baseline Characteristics of the Intent to treat population. Supplementary Table 4: Pre and post changes in immune response outcomes between treatment arms (Intent to Treat cohort n=40). Supplementary Table 5 Correlations among changes in immune response outcomes in analyzed cohort. Supplementary Figure 1: Additional graphs of immune parameters. Supplementary Figure 2: Change in immune response by treatment group and HPV status. Supplementary Figure 3: Graphic relationship between immune response measures. Supplementary Figure 4 and 5: Gating strategy for the MDSC phenotype in this study defined as CD14+ or CD15+/CD33+/HLA-DRint/low/IL-4Ra+ as well as co-expression of CD14+/CD15+/ CD33+/HLA-DRint/low/IL-4Ra+. Supplementary Figure 6: Outliers from DTH assay are graphed on a larger scale for visualization. Supplementary Figure 7: Study Schema. Supplementary Figure 8: Correlation of BMI with change in primary immune response outcomes. Supplementary Figure 9: Correlations of BSA with change in primary immune response outcomes. Supplementary Figure 10: Correlations of BSA with change in primary immune response outcomes.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361909484
Cites:
Cited by:
Related to: 10